MicroRNA-101, mitogen-activated protein kinases and mitogen-activated protein kinases phosphatase-1 in systemic lupus erythematosus

Lupus

Volumn 22, Issue 2, 2013, Pages 115-120

  Yang, J ^a   Lu, Y W ^a   Lu, M M ^a   Leng, R X ^a   Pan, H F ^a   Ye, Dong Qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

inflammatory cytokines; microRNA 101; mitogen activated protein kinase phosphatase 1; mitogen activated protein kinases; Systemic lupus erythematosus

Indexed keywords

MICRORNA 101; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; SYNAPTOPHYSIN;

ENZYME PHOSPHORYLATION; HUMAN; IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

DUAL SPECIFICITY PHOSPHATASE 1; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 84872507076     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312465779     Document Type: Review

References (42)

1. Pan HF, Ye DQ, Li XP. Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus. Nat Clin Pract Rheumatol. 2008 ; 4: 352-353 (Pubitemid 351974005)
2. Nath SK, Kilpatrick J, Harley JB. Genetics of human systemic lupus erythematosus: The emerging picture. Curr Opin Immunol. 2004 ; 16: 794-800 (Pubitemid 39423671)
3. Font J, Cervera R, Ramos-Casals M, et al. Clusters of clinical and immunologic features in systemic lupus erythematosus: Analysis of 600 patients from a single center. Semin Arthritis Rheum. 2004 ; 33: 217-230 (Pubitemid 38280821)
4. Schwartsburd PM. Chronic inflammation as inductor of pro-cancer microenvironment: Pathogenesis of dysregulated feedback control. Cancer Metastasis Rev. 2003 ; 22: 95-102 (Pubitemid 36363518)
5. Meyer O. Interferons and autoimmune disorders. Joint Bone Spine. 2009 ; 76: 464-473
6. Sugden PH, Clerk A. "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res. 1998 ; 83: 345-352 (Pubitemid 28389964)
7. Saklatvala J, Rawlinson L, Waller RJ, et al. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J Biol Chem. 1996 ; 271: 6586-6589 (Pubitemid 26104083)
8. Gorelik G, Richardson B. Key role of ERK pathway signaling in lupus. Autoimmunity. 2010 ; 43: 17-22
9. Deng C, Kaplan MJ, Yang J, et al. Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum. 2001 ; 44: 397-407
10. Wang X, Zhao Q, Matta R, et al. Inducible nitric-oxide synthase expression is regulated by mitogen-activated protein kinase phosphatase-1. J Biol Chem. 2009 ; 284: 27 123-27134
11. Zhu QY, Liu Q, Chen JX, et al. MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages. J Immunol. 2010 ; 185: 7435-7442
12. Schaeffe HJ, Weber MJ. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers. Mol Cell Biol. 1999 ; 19: 2435-2444 (Pubitemid 29144487)
13. Han J, Ulevitch RJ. Emerging targets for anti-inflammatory therapy. Nat Cell Biol. 1999 ; 1: 39-40
14. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell. 2000 ; 103: 239-252
15. Chang L, Karin M. Mammalian MAP kinase signaling cascades. Nature. 2001 ; 410: 37-40 (Pubitemid 32225829)
16. Kim C, Sano Y, Todorova K, et al. The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression. Nat Immunol. 2008 ; 9: 1019-1027
17. Coulthard LR, White DE, Jones DL, McDermott MF, Burchill SA. p38(MAPK): Stress responses from molecular mechanisms to therapeutics. Trends Mol Med. 2009 ; 15: 369-379
18. Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol. 2004 ; 5: 975-979 (Pubitemid 41057713)
19. Abraham SM, Clark AR. Dual-specificity phosphatase 1: A critical regulator of innate immune responses. Biochem Soc Trans. 2006 ; 34: 1018-1023 (Pubitemid 46768980)
20. Li L, Chen SF, Liu Y. MAP kinase phosphatase-1, a critical negative regulator of the innate immune response. Int J Clin Exp Med. 2009 ; 2: 48-67
21. Lang R, Hammer M, Mages J. DUSP meet immunology: Dual specificity MAPK phosphatases in control of the inflammatory response. J Immunol. 2006 ; 177: 7497-7504 (Pubitemid 44846262)
22. Shepherd EG, Zhao Q, Welty SE, Hansen TN, Smith CV, Liu Y. The function of mitogen-activated protein kinase phosphatase-1 in peptidoglycan-stimulated macrophages. J Biol Chem. 2004 ; 279: 54 023-54031
23. Zhao Q, Shepherd EG, Manson ME, Nelin LD, Sorokin A, Liu Y. The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: Attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. J Biol Chem. 2005 ; 280: 8101-8108 (Pubitemid 40349709)
24. Zhao Q, Wang X, Nelin LD, et al. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med. 2006 ; 203: 131-140 (Pubitemid 43139652)
25. Li J, Gorospe M, Hutter D, Barnes J, Keyse SM, Liu Y. Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation. Mol Cell Biol. 2001 ; 21: 8213-8224 (Pubitemid 33051810)
26. Wong CK, Wong PT, Tam LS, Li EK, Chen DP, Lam CW. Activation profile of intracellular mitogen-activated protein kinases in peripheral lymphocytes of patients with systemic lupus erythematosus. J Clin Immunol. 2009 ; 29: 738-746
27. Zhang S, Kaplan MH. The p38 mitogen-activated protein kinase is required for IL-12-induced IFN-γ expression. J Immunol. 2000 ; 165: 1374-1380 (Pubitemid 30604568)
28. Rincón M, Enslen H, Raingeaud J, et al. Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 1998 ; 17: 2817-2829
29. Lu HT, Yang DD, Wysk M, et al. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. 1999 ; 18: 1845-1857 (Pubitemid 29158528)
30. Iwata Y, Wada T, Furuichi K, et al. p38 Mitogen-activated protein kinase contributes to autoimmune renal injury in MRL-Fas lpr mice. J Am Soc Nephrol. 2003 ; 14: 57-67 (Pubitemid 36026297)
31. Hoffman RW. T cells in the pathogenesis of systemic lupus erythematosus. Clin Immunol. 2004 ; 113: 4-4
32. Kyttaris VC, Tsokos GC. T lymphocytes in systemic lupus erythematosus: An update. Curr Opin Rheumatol. 2004 ; 16: 548-548
33. Zhang Y, Reynolds JM, Chang SH, et al. MKP-1 is necessary for T cell activation and function. Biol Chem. 2009 ; 284: 30 815-30824
34. Huang G, Wang Y, Shi LZ, Kanneganti TD, Chi H. Signaling by the phosphatase MKP-1 in dendritic cells imprints distinct effector and regulatory T cell fates. Immunity. 2011 ; 35: 45-58
35. Clark AR. MAP kinase phosphatase 1: A novel mediator of biological effects of glucocorticoids. J Endocrinol. 2003 ; 178: 5-12 (Pubitemid 36927003)
36. Sakai A, Han J, Cato AC, Akira S, Li JD. Glucocorticoids synergize with IL-1beta to induce TLR2 expression via MAP kinase phosphatase-1-dependent dual inhibition of MAPK JNK and p38 in epithelial cells. BMC Mol Biol. 2004 ; 5: 2-2
37. Wang G, Tam LS, Li EK, et al. Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J Rheumatol. 2010 ; 37: 2516-2522
38. Leng RX, Pan HF, Qin WZ, Chen GM, Ye DQ. Role of microRNA-155 in autoimmunity. Cytokine Growth Factor Rev. 2011 ; 22: 141-147
39. Yu D, Tan AH, Hu X, et al. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature. 2007 ; 450: 299-303 (Pubitemid 350100535)
40. Dai R, Zhang Y, Khan D, et al. Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS One. 2010 ; 5: 14 302-14 302
41. Franklin CC, Kraft AS. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J Biol Chem. 1997 ; 272: 16 917-16923
42. Sun H, Charles CH, Lau LF, Tonks NK. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell. 1993 ; 75: 487-493 (Pubitemid 23335074)